Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary
- PMID: 16288054
- DOI: 10.1158/0008-5472.CAN-05-2240
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary
Abstract
Papillary serous low malignant potential (LMP) tumors are characterized by malignant features and metastatic potential yet display a benign clinical course. The role of LMP tumors in the development of invasive epithelial cancer of the ovary is not clearly defined. The aim of this study is to determine the relationships among LMP tumors and invasive ovarian cancers and identify genes contributing to their phenotypes. Affymetrix U133 Plus 2.0 microarrays (Santa Clara, CA) were used to interrogate 80 microdissected serous LMP tumors and invasive ovarian malignancies along with 10 ovarian surface epithelium (OSE) brushings. Gene expression profiles for each tumor class were used to complete unsupervised hierarchical clustering analyses and identify differentially expressed genes contributing to these associations. Unsupervised hierarchical clustering analysis revealed a distinct separation between clusters containing borderline and high-grade lesions. The majority of low-grade tumors clustered with LMP tumors. Comparing OSE with high-grade and LMP expression profiles revealed enhanced expression of genes linked to cell proliferation, chromosomal instability, and epigenetic silencing in high-grade cancers, whereas LMP tumors displayed activated p53 signaling. The expression profiles of LMP, low-grade, and high-grade papillary serous ovarian carcinomas suggest that LMP tumors are distinct from high-grade cancers; however, they are remarkably similar to low-grade cancers. Prominent expression of p53 pathway members may play an important role in the LMP tumor phenotype.
Similar articles
-
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.Oncogene. 2005 Feb 3;24(6):1053-65. doi: 10.1038/sj.onc.1208298. Oncogene. 2005. PMID: 15558012
-
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.Am J Surg Pathol. 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. Am J Surg Pathol. 2006. PMID: 17001150 Review.
-
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.Gynecol Oncol. 2010 Apr;117(1):9-17. doi: 10.1016/j.ygyno.2010.01.006. Epub 2010 Feb 1. Gynecol Oncol. 2010. PMID: 20117829
-
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17631760 Chinese.
-
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.Cancer. 2003 Jan 15;97(2):389-404. doi: 10.1002/cncr.11064. Cancer. 2003. PMID: 12518363 Review.
Cited by
-
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.BMC Cancer. 2015 Mar 17;15:135. doi: 10.1186/s12885-015-1138-8. BMC Cancer. 2015. PMID: 25886299 Free PMC article.
-
Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.Sci Rep. 2018 Sep 7;8(1):13483. doi: 10.1038/s41598-018-31030-3. Sci Rep. 2018. PMID: 30194340 Free PMC article.
-
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.Int J Mol Sci. 2019 Feb 19;20(4):890. doi: 10.3390/ijms20040890. Int J Mol Sci. 2019. PMID: 30791364 Free PMC article. Review.
-
Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer.Neoplasia. 2008 Sep;10(9):964-72. doi: 10.1593/neo.08604. Neoplasia. 2008. PMID: 18714397 Free PMC article.
-
MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma.Cell Death Dis. 2017 Feb 9;8(2):e2603. doi: 10.1038/cddis.2016.352. Cell Death Dis. 2017. PMID: 28182015 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous